The Canadian anaphylaxis action plan for kids: development and validation.

Patient Education and Counseling
Waleed AlqurashiRégis Vaillancourt

Abstract

We designed a written Canadian Anaphylaxis Action Plan for Kids (Kids' CAP) which incorporates validated pictograms with written instructions. Using a patient-centered approach, we aimed to validate the Kids' CAP and assess its impact on anaphylaxis recognition and treatment, and to determine its' perceived usefulness. Children and their parents were involved in appraising the design and written contents of the Kids' CAP. The design process consisted of a development phase and clinical validation phase. First, we assessed the readability and understandability of the Kids' CAP using validated instruments. Then, patients (12-17 years of age) and parents of patients (<12 years of age) were given the Kids' CAP during the first consultation with allergy specialists or an Emergency Department visit for anaphylaxis. Subsequently, we conducted a phone interview 2-3 weeks later to assess their comprehension of anaphylaxis management. We also used the Consumer Information Rating Form to measure the participants' perception of the design quality and usefulness of the Kids' CAP. Of the 230 participants enrolled, 205 (89%) completed the follow-up interview. The written contents of the Kid's CAP were modified to match grade 7 readability lev...Continue Reading

Citations

Oct 18, 2020·The Journal of Pediatrics·Patrick T ReevesCade M Nylund
Jan 16, 2021·CJEM·Caitlin PrendergastUNKNOWN Pediatric Emergency Research Canada (PERC) Team
Feb 8, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Laura May MilesMoshe Ben-Shoshan
Jun 23, 2021·British Journal of Clinical Pharmacology·Régis Vaillancourt, Jameason D Cameron
Oct 1, 2021·Journal of Pediatric Endocrinology & Metabolism : JPEM·Patrick T ReevesNoelle S Larson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
Régis VaillancourtAnnie Pouliot
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
Garrick MokWaleed Alqurashi
© 2021 Meta ULC. All rights reserved